Katherine Cianflone Selected Research

Atorvastatin (Lipitor)

1/2019

The Effect of Atorvastatin (and Subsequent Metformin) on Adipose Tissue Acylation-Stimulatory-Protein Concentration and Inflammatory Biomarkers in Overweight/Obese Women With Polycystic Ovary Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katherine Cianflone Research Topics

Disease

37	Obesity 05/2018 - 11/2002
35	Insulin Resistance 07/2018 - 11/2002
18	Inflammation (Inflammations) 01/2019 - 08/2009
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015 - 04/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 08/2014 - 04/2006
8	Overweight 01/2019 - 01/2007
8	Body Weight (Weight, Body) 12/2013 - 11/2002
7	Weight Loss (Weight Reduction) 01/2014 - 04/2003
5	Hyperlipidemias (Hyperlipidemia) 03/2011 - 10/2003
4	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2019 - 12/2007
4	Atherosclerosis 01/2014 - 08/2006
4	Abdominal Obesity 01/2013 - 04/2006
4	Stroke (Strokes) 08/2011 - 12/2007
3	Hypertension (High Blood Pressure) 12/2017 - 09/2005
3	Heart Failure 07/2016 - 03/2012
3	Morbid Obesity 11/2013 - 04/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2013 - 11/2006
3	Coronary Artery Disease (Coronary Atherosclerosis) 08/2011 - 10/2003
3	Ischemic Stroke 10/2010 - 12/2007
3	Dyslipidemias (Dyslipidemia) 04/2010 - 01/2003
3	Canavan Disease (Leukodystrophy, Spongiform) 02/2004 - 11/2002
2	Hypertrophy 05/2018 - 04/2011
2	Sepsis (Septicemia) 01/2018 - 05/2008
2	Metabolic Diseases (Metabolic Disease) 01/2013 - 04/2010
2	Neoplasms (Cancer) 01/2012 - 09/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2011 - 09/2009
2	Hemorrhagic Stroke 01/2009 - 12/2007
2	Hypertriglyceridemia 06/2008 - 10/2007
1	Endotoxemia 01/2018
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018
1	Obstructive Sleep Apnea 12/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2016
1	Schizophrenia (Dementia Praecox) 05/2015
1	Coronary Disease (Coronary Heart Disease) 04/2014
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2014
1	Ketosis 01/2014
1	Body Weight Changes 12/2013

Drug/Important Bio-Agent (IBA)

29	des-Arg-(77)- complement C3aIBA 01/2019 - 11/2002
23	Insulin (Novolin)FDA Link 07/2018 - 04/2003
23	LipidsIBA 05/2015 - 04/2003
18	AdipokinesIBA 12/2017 - 04/2004
15	AdiponectinIBA 06/2017 - 04/2003
13	Glucose (Dextrose)FDA LinkGeneric 07/2018 - 04/2004
13	Triglycerides (Triacylglycerol)IBA 12/2016 - 11/2002
11	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2003
11	LeptinIBA 06/2017 - 11/2002
11	Complement C3 (C3 Complement)IBA 01/2014 - 10/2003
9	Complement System Proteins (Complement)IBA 05/2015 - 08/2009
7	Hormones (Hormone)IBA 05/2018 - 02/2004
5	CholesterolIBA 12/2016 - 06/2008
5	CytokinesIBA 07/2016 - 01/2012
5	Lipoproteins (Lipoprotein)IBA 01/2014 - 09/2006
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 11/2002
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2004
4	C-Reactive ProteinIBA 12/2016 - 01/2009
4	Messenger RNA (mRNA)IBA 01/2012 - 08/2004
4	Nonesterified Fatty Acids (NEFA)IBA 06/2008 - 07/2004
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2010
3	Apolipoproteins B (ApoB)IBA 12/2016 - 04/2006
3	LDL CholesterolIBA 12/2016 - 12/2008
3	ApolipoproteinsIBA 11/2014 - 04/2003
3	Nicotinamide PhosphoribosyltransferaseIBA 11/2013 - 10/2006
3	oxidized low density lipoproteinIBA 01/2013 - 12/2008
3	EnzymesIBA 01/2013 - 09/2007
3	Cytochrome P-450 CYP2J2 (CYP2J2)IBA 03/2012 - 08/2011
3	GhrelinIBA 10/2007 - 04/2003
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 12/2007
2	Progesterone FDA LinkGeneric 11/2014 - 01/2008
2	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2014 - 10/2008
2	ProperdinIBA 01/2014 - 05/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 10/2007
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2012 - 08/2011
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2011 - 09/2006
2	Peptides (Polypeptides)IBA 04/2011 - 02/2011
2	Cystatin CIBA 10/2010 - 12/2007
2	HDL CholesterolIBA 01/2009 - 12/2008
1	Atorvastatin (Lipitor)FDA Link 01/2019
1	NF-kappa B (NF-kB)IBA 07/2018
1	AnaphylatoxinsIBA 07/2018
1	AndrogensIBA 05/2018
1	SteroidsIBA 05/2018
1	Trimetazidine (Vastarel)IBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	Interleukin-17 ReceptorsIBA 07/2016
1	Interleukin-17 (Interleukin 17)IBA 07/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 11/2014
1	telomerase RNA (bTR)IBA 04/2014
1	OrexinsIBA 01/2014
1	Immunologic Factors (Immunomodulators)IBA 01/2014
1	Glycoproteins (Glycoprotein)IBA 01/2014
1	FructoseIBA 12/2013
1	SugarsIBA 12/2013
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 12/2013
1	Adenosine Triphosphate (ATP)IBA 12/2013
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2013
1	Therapeutic UsesIBA 12/2013

Therapy/Procedure

4	Biliopancreatic Diversion 08/2014 - 01/2013
3	Bariatric Surgery 12/2017 - 08/2014
3	Therapeutics 01/2012 - 01/2003